* Sensus Healthcare Inc SRTS.OQ SRTS.O is expected
to show a
fall in quarterly revenue when it reports results
* The Boca Raton Florida-based company is expected to
report a
34.7% decrease in revenue to $5.884 million from $9.01 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Sensus Healthcare
Inc is
for a loss of 2 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Sensus
Healthcare
Inc is $8, above its last closing price of $2.19.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.08 -0.08 -0.02 Beat 73.7
Mar. 31 2023 0.12 0.13 -0.12 Missed -193.7
Dec. 31 2022 0.25 0.23 0.17 Missed -26.1
Sep. 30 2022 0.12 0.13 0.11 Missed -12.7
Jun. 0.16 0.13 0.21 Beat 59.1
30 2022
Mar. 31 2022 0.55 0.33 0.19 Missed -42.4
Dec. 31 2021 0.18 0.16 0.32 Beat 95.1
Sep. 30 2021 0.00 -0.02 0.01 Beat 160
This summary was machine generated October 30 at 11:35 GMT. All
figures in US dollars unless otherwise stated